LUNESTA WITHDRAWAL SYMPTOMS
HOW TO SUCCESSFULLY WEAN OFF LUNESTA At Home
Succeed with our Lunesta At-Home Withdrawal and Tapering Program
It is possible to break the dependence to Lunesta and discover a new approach to regain natural, restful sleep patterns. Sleeping pills such as Lunesta are only designed for short term use yet many become physically and psychologically dependent within a few days or weeks  Tapering off Lunesta is critical and Point of Return provides a safe, effective, medically driven protocol that is completed at your home. We know how important sleep is to a healthy life and we utilize a proven, holistic approach to sleeping pill withdrawal. Dependence to Lunesta places extreme demands on your body and nervous system. Point of Return implements slow reduction schedules and specifically designed nutraceuticals (high potency food based supplements that provide medical benefit) to provide symptom relief and support the body's unique needs during a Lunesta taper. Let our experts guide you on your taper journey; ways to promote sleep without interacting with Lunesta; what to avoid that increases symptoms; while providing the encouragement you need to be successful. Break your dependence to Lunesta. Point of Return doesn't just provide hope but proven success, please contact us today.*
Below is information about Lunesta, Lunesta withdrawal, and how to stop taking Lunesta naturally.
By utilizing the experienced, capable, and highly informed assistance available through Point of Return I have enabled my body, mind and spirit to recuperate. Point of Return's effective nutritional products alongside their unsurpassed support have given me a second chance. Trudy (Australia)
SUCCEED WITH OUR AT-HOME WITHDRAWAL AND TAPERING PROGRAM
I simply cannot recommend Point of Return highly enough for people whose bodies have become dependent on medications. They know, they understand and they are there to help you. Joel
WHAT IS LUNESTA WITHDRAWAL LIKE?
If you need help to Withdraw from Lunesta and would like to learn how to wean off Lunesta at home, contact our nonprofit.
I tapered successfully and today I am entirely drug free and I fall asleep every night.by Bianca
I am Lunesta FREE and sleeping great. I know, without a doubt, that had I not found Point of Return, I would still be struggling and desperate. Thank you! You gave me my life back and I will be forever grateful to you.” —RIta (Lunesta Withdrawal Success Story)
LUNESTA WITHDRAWAL HELP - HOW TO WEAN OFF LUNESTA NATURALLY & SUCCESSFULLY
Over the last 17 years Point of Return has successfully helped people in every state of the United States and all over the world to escape dependence to addictive medications. Lunesta has been shown to cause withdrawal symptoms similar to benzodiazepines.  The Point of Return Withdrawal Program is a proven, holistic approach that shows you how to wean off Lunesta while helping to ease Lunesta’s withdrawal symptoms and promoting sleep with supplements that will not interact, yet provide the necessary relief. Our Lunesta At-Home Weaning Program is done under the guidance of Our Team, Your Physician and Pharmacist, and allows you to wean off Lunesta at rates not available by the pharmaceutical companies. Our first goal is to ease symptoms and provide relief - you will not taper Lunesta until you feel better. This is where our advanced nutraceuticals and holistic approach are critical due to the unique demands placed on your body and nervous system by the Lunesta. Our withdrawal program provides healthy, proven, Drug-Free strategies to help ease Lunesta Withdrawal symptoms while supporting your well being.*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our innovative approach to sleeping pill tapering encompasses a holistic method to empower you on your path to recovery. No need to attempt Lunesta Withdrawal on your own, work with our team and get the relief and support you need.*
LUNESTA WITHDRAWAL SYMPTOMS MAY INCLUDE
- blurred vision
- body vibrations
- changes in perception
- distended abdomen
- feeling of unreality
- flu-like symptoms
- food cravings
- hair loss
- heavy limbs
- heart palpitations
- increased allergies
- increased sense of smell
- loss of balance
- metallic taste
- muscle spasms
- panic attacks
- persistent & unpleasant memories
- severe headaches
- short term memory loss
- sore mouth and tongue
- sound & light sensitivity
- speech difficulties
- suicidal thoughts
- unusually sensitive
- fear 
I cannot imagine not finding Point of Return. They have helped me get my life back. And to thinkall because I took 5 pills.by JB (USA Pastor) Lunesta Withdrawal Success
IMAGINE BEING FREE OF LUNESTA DEPENDENCY
✔ A Proven Withdrawal Program An-Home
✔ Slowly Tape Lunesta with Physician Written Tapering Protocols (these are utlized to talk to your doctor and gain their support)
✔ All-Natural Nutraceuticals to help ease symptoms and make Lunesta Withdrawal more comfortable*
✔ Professional information and support to empower you
✔ Free Mentoring on our 24/7 private Discussion Board, Phone, Email and Live Chat Support through the tapering process
Enter Discount Code SleepingPillFree for FREE Ground Shipping on your Withdrawal Program (USA & Canada Only)
LUNESTA WITHDRAWAL TIMELINE
The half-life of Lunesta, or the time to clear the body, is fairly short at 4-6 hours. Lunesta withdrawal symptoms can occur rapidly, after reducing or missing one dose. Most will feel the Lunesta withdrawals within a few hours but those that metabolize the drug more slowly may not recognize the withdrawals for several days. Rebound insomnia, confusion, anxiety, tremors and mood swings are early withdrawal symptoms. Lunesta withdrawal symptoms can intensify over days or weeks. Lunesta can cause both a psychological and physical dependency.* 
I am now drug free! I sleep better than ever, and I am back as good as new, with a few extra miles.
By Alex (Lunesta Withdrawal Success)
LUNESTA WITHDRAWAL SUCCESS STORIES
If you are suffering terribly and can't see the way out, I am here now to tell you please do NOT loose heart - there IS hope. You WILL make it. More...
Carolyn (Lunesta Withdrawal Success Story)
I tapered successfully off of Zolpidem and today I am entirely drug-free and I fall asleep every night! More...
Bianca (Lunesta Withdrawal Success Story)
I am now drug free! I sleep better than ever, and I am back as good as new, with a few extra miles. More...
Alex (Lunesta Withdrawal Success Story)
I simply cannot recommend Point of Return highly enough for people whose bodies have become dependent on medication(s). They know, they understand and they are there to help you. More...
Joel (Lunesta Withdrawal Success Story)
Thank you Point of Return for your never ending words of encouragement, advice, love and new found friendship. I am forever grateful to all of you. More...
Beck (Lunesta Withdrawal Success Story)
By utilizing the experienced, capable, and highly informed assistance available through Point of Return I have enabled my body, mind and spirit to recuperate. Point of Return's effective nutritional products alongside their unsurpassed support have given me a second chance. More...
Trudee (Lunesta Withdrawal Success Story)
Lunesta binds to a subtype of the GABA receptor. GABA is a neurotransmitter that primarily works to inhibit the activity of neurons and calm nerves. It basically counters too much stimulation on the nervous system. When Lunesta binds to the GABA receptor, it slows and stops activity in certain parts of the brain thus its classification as a hypnotic. Lunesta diminishes activity in parts of the brain that are responsible for processing thoughts. As tolerance to the drug occurs the nervous system become hyper-stimulated, increasing anxiety, insomnia, pain, cognitive impairment, and other symptoms. Lunesta should only be used short term due to the risk of drug dependence, tolerance, rebound insomnia and central nervous system related adverse effects. Once tolerance to the sleeping pill has occurred it is recommended to do a gradual dose reduction to minimize Lunesta withdrawal symptoms that resemble benzodiazepine withdrawal.
Lunesta is considered a Z-drug as all the sleeping pills in this class start with the letter Z. Zopiclone (Imovane) was the first Z-Drug released in 1989, and Eszopiclone is a sample of Zopiclone and is not marketed in the European Union following a 2009 decision denying it contained a new active substance and was too similar to Zopiclone to be patented.
Lunesta (Eszopiclone) is marketed by Sunovion Pharmaceuticals and considered a nonbenzodiazepine hypnotic, but carries the same side effects and withdrawal profile as benzodiazepines.
Lunesta was approved by the FDA in 2005 and became available in generic form in 20014. It was found to be only slightly effective in the treatment of insomnia and statistical methods found the benefit over placebo to be of questionable clinical significance.
According to a March 2015 study from Consumer Reports, sleeping pills, including Lunesta, only cause the individual to fall asleep 20 minutes faster than placebo and add only 3 to 34 minutes of total sleep time.*
LUNESTA SIDE EFFECTS AND ADVERSE REACTIONS
LUNESTA ABRUPT DISCONTINUATION SYMPTOMS MAY INCLUDE:
Abdominal & muscle cramps, vomiting, sweating, shakiness, & rarely, seizures may occur & finally rebound insomnia*
LUNESTA SIDE EFFECTS MAY INCLUDE:
Drowsiness, dizziness, lightheadedness, difficulty with coordination, memory loss or amnesia, tolerance, dependence, changes in behavior and thinking; such as more outgoing or aggressive behavior than normal, confusion, strange behavior, agitation, hallucinations, worsening of depression, suicidal thoughts*
LUNESTA ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: bronchospasm, oliguria, erythema multiforme, peptic ulce, suicidal ideation, angioedem, anaphylactoid reactions
Moderate: depression, confusion, hallucinations, memory impairment, myasthenia, oral ulceration, urinary incontinence, ataxia, vaginitis, melena, hypertonia, conjunctivitis, dysuria, cholelithiasis, hematuria, hypertension, lymphadenopathy, nystagmus, stomatitis, heat intolerance, anemia, hostility, cystitis, contact dermatitis, hypercholesterolemia, vaginal bleeding, peripheral neuropathy, euphoria, gastritis, hyperlipidemia, hypokalemia, myopathy, hepatomegaly, neuritis, photophobia, colitis, hepatitis, hyperesthesia, iritis, dehydration, phlebitis, hyperacusis, gout, dysphagia, furunculosis, migraine, chest pain (unspecified), peripheral edema, impaired cognition, dyspnea, complex sleep-related behaviors
Mild: dysgeusia, headache, drowsiness, infection, dizziness, xerostomia, dyspepsia, restlessness, nausea, diarrhea, rash, anxiety, abnormal dreams, vomiting, gynecomastia, dysmenorrhea, libido decrease, increased urinary frequency, fever, laryngitis, insomnia, xerophthalmia, hiccups, amenorrhea, tinnitus, xerosis, epistaxis, vertigo, anorexia, otalgia, skin discoloration, diaphoresis, malaise, weight loss, urticaria, halitosis, acne vulgaris, emotional lability, breast enlargement , muscle cramps, appetite stimulation, alopecia, photosensitivity, weight gain, paresthesias, polydipsia, agitation, menorrhagia, hirsutism, mydriasis, ptosis, tremor, maculopapular rash, dysosmia, somnambulism*
LUNESTA BOXED WARNINGS: per PDR:
Behavioral changes, CNS depression, coadministration with other CNS depressants, complex sleep-related behaviors, driving or operating machinery, drug-induced complex sleep-related behaviors, ethanol ingestion
Sedative-hypnotics can cause complex sleep-related behaviors such as phone calls, sexual activity, preparing and eating food, or sleep driving while not fully awake and in some cases having no memory of the event. These behaviors appear to be more frequent with nonbenzodiazepine benzodiazepine-receptor agonists (NBRAs), such as eszopiclone, than other sedative-hypnotics. Although rare, serious injuries or death have occurred; therefore, eszopiclone and other NBRAs are contraindicated in patients with a history of drug-induced complex sleep-related behaviors. Patients should be informed of the risks before receiving any medication from this class, including instructions to discontinue the medication if they experience a sleep-related episode and to contact their healthcare provider immediately. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of NBRAs to the FDA MedWatch Safety Information and Adverse Event Reporting Program. Because eszopiclone has a rapid onset of action and causes CNS depression, it should only be administered before retiring. Patients should be instructed to avoid driving or operating machinery or performing other tasks requiring mental alertness after taking eszopiclone. Because eszopiclone can cause drowsiness and a decreased level of consciousness, there is a higher risk of falls, particularly in the elderly, with the potential for subsequent severe injuries. A variety of abnormal thinking and behavioral changes have been reported to occur in association with the use of sedative/hypnotics. Some of these changes may be characterized by decreased inhibition (e.g., aggressiveness and extroversion that seem out of character), similar to effects produced by alcohol and other CNS depressants. Other reported behavioral changes have included bizarre behavior, agitation, hallucinations, and depersonalization. Amnesia and other neuropsychiatric symptoms may occur unpredictably. Any emergence of changes in thinking or behavior should be evaluated. Although such behaviors may occur with the use of the drug alone at therapeutic doses, the use of higher doses, or the use of the drug with alcohol or the coadministration with other CNS depressants appears to increase the risks. Advise patients to avoid ethanol ingestion. Eszopiclone can cause next-day psychomotor and memory impairment, with patients often unaware that they are impaired. Results from one study indicate that peak impairment after a 3 mg dose occurs 7.5 hours later, with clinically relevant effects still present at 11.5 hours after the dose. Lower initial dosages of eszopiclone should be considered in patients taking other CNS depressant therapies.*
LUNESTA TECHNICAL DATA AND REFERENCES
Following rapid dose decrease or abrupt discontinuation of the use of sedative/hypnotics, there have been reports of signs and symptoms similar to those associated with withdrawal from other CNS-depressant drugs [see Drug Abuse and Dependence (9)].
Withdrawal Effects: symptoms may occur with rapid dose reduction or discontinuation.*
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with Your physician to help you with your drug withdrawal process and with his or her consent throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..